 |
 |

Clonidine and NaltrexoneA Safe, Effective, and Rapid Treatment of Abrupt Withdrawal From Methadone Therapy
Dennis S. Charney, MD;
Charles E. Riordan, MD;
Herbert D. Kleber, MD;
Michele Murburg, MD;
Paula Braverman;
David E. Sternberg, MD;
George R. Heninger, MD;
D. Eugene Redmond, MD
Arch Gen Psychiatry. 1982;39(11):1327-1332.
Abstract
 |  |
Clonidine hydrochloride and naltrexone hydrochloride, given in combination, were found to provide a safe, effective, and extremely rapid treatment of abrupt withdrawal from methadone hydrochloride therapy. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, ten (91%) of 11 patients were able to withdraw completely from methadone therapy by the end of a six-day period. Six days of clonidine hydrochloride treatment, with a peak mean dose of 2.9 mg/day on treatment day 2, attenuated the withdrawalinducing effects of naltrexone. Naltrexone hydrochloride was gradually increased from an initial 1-mg dose on treatment day 2 to a 50-mg maintenance dose on treatment day 5 without an associated increase in withdrawal symptoms. Clonidine significantly decreased BP without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, and muscular aching were most resistant to treatment, but at discharge most patients were completely asymptomatic.
Author Affiliations
From the Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Conn.
Footnotes
Accepted for publication April 21, 1982.
Reprint requests to Connecticut Mental Health Center, Yale University School of Medicine, 34 Park St, New Haven, CT 06508 (Dr Charney).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Effect of Clonidine on Gastrointestinal Side Effects Associated with Ultra-Rapid Opioid Detoxification
Ma et al.
Anesth. Analg. 2003;96:1409-1412.
ABSTRACT
| FULL TEXT
Activation of Coeruleospinal Noradrenergic Inhibitory Controls during Withdrawal from Morphine in the Rat
Rohde and Basbaum
J. Neurosci. 1998;18:4393-4402.
ABSTRACT
| FULL TEXT
Methadone Maintenance in the Treatment of Narcotics Addiction
Tommasello
Journal of Pharmacy Practice 1991;4:357-361.
ABSTRACT
Cerebrospinal Fluid 3-Methoxy-4-hydroxyphenylglycol and Norepinephrine Levels in Alcohol Withdrawal: Correlations With Clinical Signs
Hawley et al.
Arch Gen Psychiatry 1985;42:1056-1062.
ABSTRACT
|